Cite
HARVARD Citation
Guo, R. et al. (2018). Increased von Willebrand factor over decreased ADAMTS‐13 activity is associated with poor prognosis in patients with advanced non‐small‐cell lung cancer. Journal of clinical laboratory analysis. 32 (1), p. n/a. [Online].